VCAM1 and COVID-19: Additionally, we observed a reduction of s-VCAM-1 in all patient groups throughout hospitalization, which is in accordance with findings of comparable VCAM-1 concentrations in long COVID-19 patients and controls [44] if we assume that VCAM-1 returns to normal in some months.